NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NICHD E-141-2019-0-PCT-02 MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME PCT PCT PCT/US2021/036809 Expired
NCATS E-229-2020-0-PCT-02 Methods Of Combination Therapy For Treatment Of Mucopolysaccharidosis Type IVA Using Human Recombinant Nacetylgalactosamine
6-sulfatase (hrGALNS) And Pharmacological Chaperones 		PCT PCT PCT/IB2021/055134 Expired
NICHD E-141-2019-0-EP-08 MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME EP National Stage 21745474.3 Pending
NCI E-007-2019-0-EP-04 TP5, A PEPTIDE INHIBITOR OF ABERRANT AND HYPERACTIVE CDK5/P25 AS TREATMENT FOR CANCER EP National Stage 19817052.4 Issued
NICHD E-141-2019-0-CA-03 MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME CA National Stage 3184810 Pending
NCI E-215-2018-0-US-09 2'-HALOGENATED-4'-THIO-2'-DEOXY-5-AZACYTIDINE ANALOGS AND USE THEREOF US CON 17/343,350 11254662 Issued PDF
NCI E-078-2020-0-AU-03 SIZE-DEPENDENT BRAIN AND LYMPHATIC DISTRIBUTION OF MACROMOLECULAR DRUG DELIVERY PLATFORM AU National Stage 2021289443 Pending
NCI E-078-2020-0-PCT-02 SIZE-DEPENDENT BRAIN AND LYMPHATIC DISTRIBUTION OF MACROMOLECULAR DRUG DELIVERY PLATFORM PCT PCT PCT/US2021/036548 Expired
NCI E-078-2020-0-CA-04 SIZE-DEPENDENT BRAIN AND LYMPHATIC DISTRIBUTION OF MACROMOLECULAR DRUG DELIVERY PLATFORM CA National Stage 3186654 Pending
NEI E-044-2018-0-US-03 EXOSOMES AND MIRNA TO TREAT GLAUCOMA US DIV 17/341,057 11806369 Issued PDF
NCATS E-198-2016-0-US-08 Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling US CON 17/340,589 11654147 Issued PDF
NCI E-230-2012-0-AU-63 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 AU DIV 2021203746 Pending
NIAID E-143-2018-0-PCT-02 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS PCT PCT PCT/US2021/036030 Expired
NIAID E-143-2018-0-US-02 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS US National Stage 18/008,393 Pending
NIAID E-143-2018-0-CN-01 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS CN National Stage 202180058491.3 Pending
NIAID E-143-2018-0-EP-01 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS EP National Stage 21736442.1 Pending
NIAID E-143-2018-0-HK-01 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS HK EP 62023071471.4 Pending
NIAID E-143-2018-0-JP-01 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS JP National Stage 2022-574455 Pending
NIDDK E-022-2019-0-US-03 A1 ADENOSINE RECEPTOR AGONISTS AND METHODS OF USE THEREOF US National Stage 17/299,890 Pending
NIAID E-143-2018-0-RU-01 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS RU National Stage 2022135077 Pending
NIAID E-143-2018-0-IN-01 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS IN National Stage 202217074567 Pending
NIAID E-143-2018-0-AU-01 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS AU National Stage 2021285997 Pending
NHLBI E-342-2013-0-US-07 Human IPSC-derived Vascular-related And Hematopoetic Cells For Therapies And Toxicology/drug Screenings US CON 17/337,978 Pending
NIA E-092-2011-0-EP-13 The Use Of (2R,6R)-Hydroxynorketamine, (S)-Dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain EP DIV 21177619.0 Pending
NCI E-219-2013-1-US-01 USE OF CYSTEAMINE AND DERIVATIVES THEREOF TO SUPPRESS TUMOR METASTASES US CON 17/337,095 11844769 Issued PDF
NCATS E-169-2019-0-PCT-02 DIFFERENTIATION OF TROPHECTODERM LINEAGE CELLS FROM PLURIPOTENT STEM CELLS PCT PCT PCT/US2021/035527 Expired
NCI E-099-2014-0-JP-13 MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF JP DIV 2021-090964 Issued
NCI E-171-2018-7-GB-10 MODIFIED CELLS AND METHODS OF THERAPY GB DIV 2107650.0 Issued
NCI E-171-2018-7-GB-09 MODIFIED CELLS AND METHODS OF THERAPY GB DIV 2107651.8 Issued
NEI E-033-2021-0-PCT-02 EXOSOMES COMPRISING IL-35 OR IL-27 AND USES THEREOF PCT PCT PCT/US2021/034778 Expired
NEI E-247-2020-0-PCT-02 BILAYER OF RETINAL PIGMENTED EPITHELIUM AND PHOTORECEPTOR PRECURSORS PCT PCT PCT/US2021/034851 Expired
NEI E-247-2020-0-US-02 BILAYER OF RETINAL PIGMENTED EPITHELIUM AND PHOTORECEPTOR PRECURSORS US National Stage 18/000,008 Pending
NIAID E-021-2019-0-US-20 CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN US CON 17/332,901 Pending
NCI E-127-2018-0-CA-01 Compositions and Methods for Treating Cancer with Anti-CD38 Immunotherapy CA National Stage 3121244 Pending
NCI E-042-2014-0-MX-28 Chimeric Antigen Receptors Targeting CD-19 MX DIV MX/a/2021/006239 Pending
Leidos E-184-2020-0-PCT-02 TARGETING THE CHOLECYSTOKININ-B RECEPTOR FOR IMAGING AND EARLY DETECTION OF PANCREATIC CANCER AND PRE-CANCEROUS LESIONS PCT PCT PCT/US2021/034339 Expired
NHLBI E-149-2018-0-US-03 Use Of VDAC Inhibitor VBIT 4 In Lupus Treatment US National Stage 17/297,017 Pending
NCI E-042-2014-0-IL-29 Chimeric Antigen Receptors Targeting CD-19 IL DIV 283423 Issued
NCI E-008-2014-2-JP-16 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same JP DIV 2021-086485 Issued
NCI E-166-2018-0-EP-07 HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS EP National Stage 19805442.1 Pending
NIAID E-260-2014-0-US-06 RECOMBINANT METAPNEUMOVIRUS F PROTEINS AND THEIR USE US DIV 17/334,505 11786591 Issued PDF
NCI E-029-2022-1-PCT-02 Compositions And Methods For Prevention Of Coronavirus Infection PCT PCT PCT/US2021/033009 Expired
NCI E-029-2022-1-US-02 Compositions And Methods For Prevention Of Coronavirus Infection US National Stage 17/999,235 Pending
NIBIB E-047-2019-0-US-07 CONJUGATES OF BIVALENT EVANS BLUE DYE DERIVATIVES AND METHODS OF USE US National Stage 17/294,914 Issued
NEI E-015-2019-0-US-11 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE US National Stage 17/295,030 Pending
CC E-128-2020-0-US-02 ISOLATION DEVICES TO REDUCE CONTAMINATION DURING IMAGING OF PATIENTS US ORD 17/323,763 Pending
NCI E-029-2022-1-EP-01 Compositions And Methods For Prevention Of Coronavirus Infection EP National Stage 21809656.8 Pending
NIDDK E-028-2018-1-HK-08 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS HK National Stage 62021031364.4 Abandoned
NCATS E-035-2020-1-US-02 TREATING PRIMARY OR IDIOPATHIC HYPEROXALURIA WITH SMALL MOLECULE INHIBITORS OF LACTATE DEHYDROGENASE US ORD 17/322,260 11752138 Issued PDF
NCI E-257-2009-1-US-26 Use Of IL-15 To Increase Thymic Output US CON 17/322,086 Abandoned